BCART — Biocartis NV Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Biocartis NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -48.2 | -64.1 | -62.9 | -71.5 | -65.4 |
| Depreciation | |||||
| Non-Cash Items | 6 | 10.1 | 17.8 | 12 | 19.9 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.11 | -9.96 | -3.85 | -16.1 | -9.89 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -42 | -54.3 | -39.3 | -65.7 | -44.9 |
| Capital Expenditures | -5.83 | -2.52 | -3.02 | -3.75 | -1.94 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.008 | -2.98 | -0.987 | 0.007 | -3.49 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.82 | -5.5 | -4.01 | -3.75 | -5.43 |
| Financing Cash Flow Items | -0.029 | -0.037 | -0.05 | -0.115 | -0.073 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.51 | 175 | -11.5 | -1.2 | 22.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -49.2 | 115 | -55.1 | -70.1 | -27.4 |